Orca-Q
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
What will happen during the trial?
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 186 patients (estimated)
- Sponsors
- Orca Biosystems, Inc.
- Tags
- Allogeneic Stem Cell Transplant
- Trial Type
- Supportive
- Last Update
- SparkCures ID
- 1669
- NCT Identifier
- NCT03802695
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.